Sibutramine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sibutramine" in English language version.

refsWebsite

Global rank English rank

31web.archive.org

1^st place

14nih.gov

4^th place

11doi.org

2^nd place

8fda.gov

447^th place

338^th place

4semanticscholar.org

11^th place

8^th place

3drugs.com

399^th place

333^rd place

2tga.gov.au

3,984^th place

2,622^nd place

1in.gov.br

3,151^st place

5,932^nd place

1hc-sc.gc.ca

low place

8,167^th place

1sda.gov.cn

low place

1abbott.de

low place

1archive.today

14^th place

1info.gov.hk

2,665^th place

5,448^th place

1pib.nic.in

1,184^th place

835^th place

1medsafe.govt.nz

low place

1inquirer.net

437^th place

260^th place

1moph.go.th

low place

1bbc.co.uk

8^th place

10^th place

1wsj.com

79^th place

65^th place

1rxlist.com

7,927^th place

6,815^th place

1harvard.edu

18^th place

17^th place

1citizen.org

low place

1cbsnews.com

108^th place

80^th place

1uq.edu.au

3,558^th place

2,403^rd place

1handle.net

102^nd place

76^th place

1practicaldiabetesinternational.com

low place

1europa.eu

68^th place

117^th place

1nytimes.com

7^th place

1webmd.com

1,169^th place

1,075^th place

1cnn.com

28^th place

26^th place

1cbc.ca

115^th place

82^nd place

1mhra.gov.uk

low place

1irishtimes.com

266^th place

182^nd place

1msn.com

117^th place

145^th place

1npr.org

92^nd place

72^nd place

abbott.de

(in German) Sibutramin-Vertrieb in der Europäischen Union ausgesetzt [1] Archived 2012-07-19 at archive.today. Abbott Laboratories in Germany. Press Release 2010-01-21. Retrieved 2010-01-27

archive.today

(in German) Sibutramin-Vertrieb in der Europäischen Union ausgesetzt [1] Archived 2012-07-19 at archive.today. Abbott Laboratories in Germany. Press Release 2010-01-21. Retrieved 2010-01-27

bbc.co.uk

news.bbc.co.uk

"Top obesity drug sibutramine being suspended". BBC News. 2010-01-22. Archived from the original on 2010-01-25. Retrieved 2010-01-22.

cbc.ca

"Herbal diet product poses heart risk". CBC News. March 26, 2010. Archived from the original on March 28, 2010. Retrieved March 26, 2010.

cbsnews.com

Hearing of 17 November 2004. "Insider: FDA Won't Protect Public". CBS News. 19 November 2004. Archived from the original on 19 May 2006.

citizen.org

Wolfe SM, Sasich LD, Barbehenn E (March 19, 2002). "Petition to FDA to ban the diet drug sibutramine (MERIDIA) (HRG Publication #1613)". Public Citizen. Archived from the original on 2006-12-19. Retrieved 2007-04-29.

cnn.com

"Fake Alli diet pills can pose health risks". CNN.com. January 23, 2010. Archived from the original on 2010-01-25. Retrieved 2010-01-24.

doi.org

Buckett WR, Thomas PC, Luscombe GP (1988). "The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12 (5): 575–584. doi:10.1016/0278-5846(88)90003-6. PMID 2851857. S2CID 24787523.
Siebenhofer A, Winterholer S, Jeitler K, Horvath K, Berghold A, Krenn C, Semlitsch T (January 2021). "Long-term effects of weight-reducing drugs in people with hypertension". The Cochrane Database of Systematic Reviews. 1 (1): CD007654. doi:10.1002/14651858.CD007654.pub5. PMC 8094237. PMID 33454957.
Nisoli E, Carruba MO (October 2000). "An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action". Obesity Reviews. 1 (2): 127–139. doi:10.1046/j.1467-789x.2000.00020.x. PMID 12119986. S2CID 20553857.
Rothman RB, Baumann MH (May 2009). "Serotonergic drugs and valvular heart disease". Expert Opinion on Drug Safety. 8 (3): 317–329. doi:10.1517/14740330902931524. PMC 2695569. PMID 19505264.
Kim KA, Song WK, Park JY (November 2009). "Association of CYP2B6, CYP3A5, and CYP2C19 genetic polymorphisms with sibutramine pharmacokinetics in healthy Korean subjects". Clinical Pharmacology and Therapeutics. 86 (5): 511–518. doi:10.1038/clpt.2009.145. PMID 19693007. S2CID 24789264.
Glick SD, Haskew RE, Maisonneuve IM, Carlson JN, Jerussi TP (May 2000). "Enantioselective behavioral effects of sibutramine metabolites". European Journal of Pharmacology. 397 (1): 93–102. doi:10.1016/s0014-2999(00)00216-8. PMID 10844103.
Jain DS, Subbaiah G, Sanyal M, Shrivastav PS, Pal U, Ghataliya S, et al. (2006). "Liquid chromatography/electrospray ionization tandem mass spectrometry validated method for the simultaneous quantification of sibutramine and its primary and secondary amine metabolites in human plasma and its application to a bioequivalence study". Rapid Communications in Mass Spectrometry. 20 (23): 3509–3521. Bibcode:2006RCMS...20.3509J. doi:10.1002/rcm.2760. PMID 17072906.
Thevis M, Sigmund G, Schiffer AK, Schänzer W (2006). "Determination of N-desmethyl- and N-bisdesmethyl metabolites of Sibutramine in doping control analysis using liquid chromatography-tandem mass spectrometry". European Journal of Mass Spectrometry. 12 (2). Chichester, England: 129–36. doi:10.1255/ejms.797. PMID 16723754. S2CID 23359461.
James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, et al. (September 2010). "Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects" (PDF). The New England Journal of Medicine. 363 (10): 905–917. doi:10.1056/NEJMoa1003114. hdl:2437/111825. PMID 20818901.
Haslam D (April 2010). "Sibutramine: gone, but not forgotten" (PDF). Pract Diab Int. 27 (3): 96–97. doi:10.1002/pdi.1453. Archived from the original (PDF) on 26 July 2015.
Müller D, Weinmann W, Hermanns-Clausen M (March 2009). "Chinese slimming capsules containing sibutramine sold over the Internet: a case series". Deutsches Ärzteblatt International. 106 (13): 218–222. doi:10.3238/arztebl.2009.0218. PMC 2680571. PMID 19471631.

drugs.com

"Sibutramine - Drugs.com". drugs.com. Archived from the original on 2017-10-08. Retrieved 2017-10-08.
"FDA Alert: Slimming Beauty Bitter Orange Slimming Capsules: Undeclared Drug Ingredient". drugs.com. Archived from the original on 2018-08-25. Retrieved 2018-01-23.
"FDA Alert: Slim Xtreme Herbal Slimming Capsule: Undeclared Drug Ingredient". drugs.com. Archived from the original on 2018-08-25. Retrieved 2018-01-23.

europa.eu

ema.europa.eu

"European Medicines Agency recommends suspension of marketing authorisations for sibutramine" (PDF). European Medicines Agency. January 21, 2010. Archived from the original (PDF) on 2010-04-01.

fda.gov

"The FDA August 2010 drug safety update". fda.gov. Archived from the original on 2017-01-12. Retrieved 2019-12-16.
"Meridia (sibutramine hydrochloride): Follow-Up to an Early Communication about an Ongoing Safety Review". United States Food and Drug Administration. 1 February 2010. Archived from the original on 6 January 2012.
"Meridia (sibutramine hydrochloride monohydrate) Capsules CIV. Full Prescribing Information" (PDF). Abbott Laboratories, North Chicago, IL 60064, U.S.A. Archived (PDF) from the original on 17 February 2017. Retrieved 6 February 2016.
"FDA APPROVES SIBUTRAMINE TO TREAT OBESITY" (Press release). U.S. Food and Drug Administration. November 24, 1997. Retrieved 2007-04-29.
Center for Drug Evaluation and Research (2019-06-28). "FDA Drug Safety Communication: FDA Recommends Against the Continued Use of Meridia (sibutramine)". FDA. Archived from the original on 2022-12-12. Retrieved 2022-12-12.
"FDA warns consumers about tainted weight loss pills" (Press release). U.S. Food and Drug Administration. 22 December 2008.
"Consumer directed questions and answers about FDA's initiative against contaminated weight loss products". U.S. Food and Drug Administration Center for Drug Evaluation and Research. 22 December 2008. Archived from the original on 17 March 2009. Retrieved 16 December 2019.
"PRock Marketing, LLC Issues a Voluntary Nationwide Recall of All weight loss formulas and variation of formulas of Reduce Weight Fruta Planta/Reduce Weight Dietary Supplement". United States Food and Drug Administration. Archived from the original on 23 March 2012.

handle.net

hdl.handle.net

James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, et al. (September 2010). "Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects" (PDF). The New England Journal of Medicine. 363 (10): 905–917. doi:10.1056/NEJMoa1003114. hdl:2437/111825. PMID 20818901.

harvard.edu

ui.adsabs.harvard.edu

Jain DS, Subbaiah G, Sanyal M, Shrivastav PS, Pal U, Ghataliya S, et al. (2006). "Liquid chromatography/electrospray ionization tandem mass spectrometry validated method for the simultaneous quantification of sibutramine and its primary and secondary amine metabolites in human plasma and its application to a bioequivalence study". Rapid Communications in Mass Spectrometry. 20 (23): 3509–3521. Bibcode:2006RCMS...20.3509J. doi:10.1002/rcm.2760. PMID 17072906.

hc-sc.gc.ca

Health Canada Endorsed Important Safety Information on MERIDIA (Sibutramine Hydrochloride Monohydrate) Archived 2013-01-11 at the Wayback Machine: Subject: Voluntary withdrawal of Meridia (sibutramine) capsules from the Canadian market.

in.gov.br

Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.

info.gov.hk

"De-registration of pharmaceutical products containing sibutramine" (Press release). info.gov in Hong Kong. November 2, 2010. Retrieved 2010-11-08.

inquirer.net

business.inquirer.net

"FDA warns online sellers of banned slimming pills". January 12, 2014. Archived from the original on January 15, 2014. Retrieved February 20, 2014.

irishtimes.com

Pope C. "Seizures of illegal medicines rise". The Irish Times. Archived from the original on 2012-10-24. Retrieved 2011-03-25.

medsafe.govt.nz

"Withdrawal of Sibutramine (Reductil) in New Zealand" (Press release). MedSafe in New Zealand. October 11, 2010. Retrieved 2012-11-06.

mhra.gov.uk

"Press release: Warning over unlicensed herbal Payouji tea and Pai You Guo Slim Capsules". United Kingdom Medicines & Healthcare Products Regulatory Agency. 20 October 2010. Archived from the original on 9 February 2012.

moph.go.th

elib.fda.moph.go.th

"Thai FDA reveals voluntary withdrawal of sibutramine from the Thai market" (PDF) (Press release). Food and Drug Administration of Thailand. October 20, 2010. Archived from the original (PDF) on 2011-05-11. Retrieved 2010-12-22.

msn.com

vitals.msnbc.msn.com

Carroll L (19 October 2011). "'Natural' diet pills tainted with banned prescription drug". MSNBC. Archived from the original on 11 January 2012.

nih.gov

pubmed.ncbi.nlm.nih.gov

Buckett WR, Thomas PC, Luscombe GP (1988). "The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12 (5): 575–584. doi:10.1016/0278-5846(88)90003-6. PMID 2851857. S2CID 24787523.
Siebenhofer A, Winterholer S, Jeitler K, Horvath K, Berghold A, Krenn C, Semlitsch T (January 2021). "Long-term effects of weight-reducing drugs in people with hypertension". The Cochrane Database of Systematic Reviews. 1 (1): CD007654. doi:10.1002/14651858.CD007654.pub5. PMC 8094237. PMID 33454957.
Nisoli E, Carruba MO (October 2000). "An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action". Obesity Reviews. 1 (2): 127–139. doi:10.1046/j.1467-789x.2000.00020.x. PMID 12119986. S2CID 20553857.
Rothman RB, Baumann MH (May 2009). "Serotonergic drugs and valvular heart disease". Expert Opinion on Drug Safety. 8 (3): 317–329. doi:10.1517/14740330902931524. PMC 2695569. PMID 19505264.
Heal DJ, Aspley S, Prow MR, Jackson HC, Martin KF, Cheetham SC (August 1998). "Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine". International Journal of Obesity and Related Metabolic Disorders. 22 (Suppl 1): S18-28, discussion S29. PMID 9758240.
Kim KA, Song WK, Park JY (November 2009). "Association of CYP2B6, CYP3A5, and CYP2C19 genetic polymorphisms with sibutramine pharmacokinetics in healthy Korean subjects". Clinical Pharmacology and Therapeutics. 86 (5): 511–518. doi:10.1038/clpt.2009.145. PMID 19693007. S2CID 24789264.
Glick SD, Haskew RE, Maisonneuve IM, Carlson JN, Jerussi TP (May 2000). "Enantioselective behavioral effects of sibutramine metabolites". European Journal of Pharmacology. 397 (1): 93–102. doi:10.1016/s0014-2999(00)00216-8. PMID 10844103.
Jain DS, Subbaiah G, Sanyal M, Shrivastav PS, Pal U, Ghataliya S, et al. (2006). "Liquid chromatography/electrospray ionization tandem mass spectrometry validated method for the simultaneous quantification of sibutramine and its primary and secondary amine metabolites in human plasma and its application to a bioequivalence study". Rapid Communications in Mass Spectrometry. 20 (23): 3509–3521. Bibcode:2006RCMS...20.3509J. doi:10.1002/rcm.2760. PMID 17072906.
Thevis M, Sigmund G, Schiffer AK, Schänzer W (2006). "Determination of N-desmethyl- and N-bisdesmethyl metabolites of Sibutramine in doping control analysis using liquid chromatography-tandem mass spectrometry". European Journal of Mass Spectrometry. 12 (2). Chichester, England: 129–36. doi:10.1255/ejms.797. PMID 16723754. S2CID 23359461.
James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, et al. (September 2010). "Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects" (PDF). The New England Journal of Medicine. 363 (10): 905–917. doi:10.1056/NEJMoa1003114. hdl:2437/111825. PMID 20818901.
Müller D, Weinmann W, Hermanns-Clausen M (March 2009). "Chinese slimming capsules containing sibutramine sold over the Internet: a case series". Deutsches Ärzteblatt International. 106 (13): 218–222. doi:10.3238/arztebl.2009.0218. PMC 2680571. PMID 19471631.

ncbi.nlm.nih.gov

Siebenhofer A, Winterholer S, Jeitler K, Horvath K, Berghold A, Krenn C, Semlitsch T (January 2021). "Long-term effects of weight-reducing drugs in people with hypertension". The Cochrane Database of Systematic Reviews. 1 (1): CD007654. doi:10.1002/14651858.CD007654.pub5. PMC 8094237. PMID 33454957.
Rothman RB, Baumann MH (May 2009). "Serotonergic drugs and valvular heart disease". Expert Opinion on Drug Safety. 8 (3): 317–329. doi:10.1517/14740330902931524. PMC 2695569. PMID 19505264.
Müller D, Weinmann W, Hermanns-Clausen M (March 2009). "Chinese slimming capsules containing sibutramine sold over the Internet: a case series". Deutsches Ärzteblatt International. 106 (13): 218–222. doi:10.3238/arztebl.2009.0218. PMC 2680571. PMID 19471631.

npr.org

Cohen R (12 October 2018). "No Wonder It Works So Well: There May Be Viagra In That Herbal Supplement". NPR.org. Archived from the original on 2018-10-13. Retrieved 2018-10-14.

nytimes.com

Andrew Pollack (October 8, 2010). "Abbott Labs Withdraws Meridia From Market". The New York Times. Archived from the original on March 28, 2017. Retrieved February 25, 2017.

pib.nic.in

"Banned Medicines" (Press release). Ministry of Health and Family Welfare. February 10, 2011. Retrieved 2011-03-15.

practicaldiabetesinternational.com

Haslam D (April 2010). "Sibutramine: gone, but not forgotten" (PDF). Pract Diab Int. 27 (3): 96–97. doi:10.1002/pdi.1453. Archived from the original (PDF) on 26 July 2015.

rxlist.com

"Meridia Side Effects, and Drug Interactions". RxList.com. 2007. Archived from the original on 2008-08-09. Retrieved 2007-04-29.

sda.gov.cn

"Notification of Termination of Production, Sale, and Usage of Sibutramine Preparations and Their Active Pharmaceutical Ingredient". sda.gov in People's Republic of China. October 30, 2010. Archived from the original on 2011-10-07. Retrieved 2011-05-21.

semanticscholar.org

api.semanticscholar.org

Buckett WR, Thomas PC, Luscombe GP (1988). "The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12 (5): 575–584. doi:10.1016/0278-5846(88)90003-6. PMID 2851857. S2CID 24787523.
Nisoli E, Carruba MO (October 2000). "An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action". Obesity Reviews. 1 (2): 127–139. doi:10.1046/j.1467-789x.2000.00020.x. PMID 12119986. S2CID 20553857.
Kim KA, Song WK, Park JY (November 2009). "Association of CYP2B6, CYP3A5, and CYP2C19 genetic polymorphisms with sibutramine pharmacokinetics in healthy Korean subjects". Clinical Pharmacology and Therapeutics. 86 (5): 511–518. doi:10.1038/clpt.2009.145. PMID 19693007. S2CID 24789264.
Thevis M, Sigmund G, Schiffer AK, Schänzer W (2006). "Determination of N-desmethyl- and N-bisdesmethyl metabolites of Sibutramine in doping control analysis using liquid chromatography-tandem mass spectrometry". European Journal of Mass Spectrometry. 12 (2). Chichester, England: 129–36. doi:10.1255/ejms.797. PMID 16723754. S2CID 23359461.

tga.gov.au

"Sibutramine (Reductil) - withdrawal in Australia". Therapeutic Goods Administration (Tga). Therapeutic Goods Administration, Department of Health, Australian Government. 2010. Archived from the original on 2014-07-03. Retrieved 2014-10-06.
"Majestic slimming capsules: Safety advisory". Therapeutic Goods Administration. Australian Government. 9 November 2012. Archived from the original on 3 July 2014. Retrieved 22 November 2012.

uq.edu.au

espace.library.uq.edu.au

James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, et al. (September 2010). "Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects" (PDF). The New England Journal of Medicine. 363 (10): 905–917. doi:10.1056/NEJMoa1003114. hdl:2437/111825. PMID 20818901.

web.archive.org

Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
"Sibutramine (Reductil) - withdrawal in Australia". Therapeutic Goods Administration (Tga). Therapeutic Goods Administration, Department of Health, Australian Government. 2010. Archived from the original on 2014-07-03. Retrieved 2014-10-06.
Health Canada Endorsed Important Safety Information on MERIDIA (Sibutramine Hydrochloride Monohydrate) Archived 2013-01-11 at the Wayback Machine: Subject: Voluntary withdrawal of Meridia (sibutramine) capsules from the Canadian market.
"Notification of Termination of Production, Sale, and Usage of Sibutramine Preparations and Their Active Pharmaceutical Ingredient". sda.gov in People's Republic of China. October 30, 2010. Archived from the original on 2011-10-07. Retrieved 2011-05-21.
"FDA warns online sellers of banned slimming pills". January 12, 2014. Archived from the original on January 15, 2014. Retrieved February 20, 2014.
"Thai FDA reveals voluntary withdrawal of sibutramine from the Thai market" (PDF) (Press release). Food and Drug Administration of Thailand. October 20, 2010. Archived from the original (PDF) on 2011-05-11. Retrieved 2010-12-22.
"Top obesity drug sibutramine being suspended". BBC News. 2010-01-22. Archived from the original on 2010-01-25. Retrieved 2010-01-22.
Rockoff JD, Dooren JC (October 8, 2010). "Abbott Pulls Diet Drug Meridia Off US Shelves". The Wall Street Journal. Archived from the original on 11 October 2010. Retrieved 8 October 2010.
"Sibutramine - Drugs.com". drugs.com. Archived from the original on 2017-10-08. Retrieved 2017-10-08.
"The FDA August 2010 drug safety update". fda.gov. Archived from the original on 2017-01-12. Retrieved 2019-12-16.
"Meridia (sibutramine hydrochloride): Follow-Up to an Early Communication about an Ongoing Safety Review". United States Food and Drug Administration. 1 February 2010. Archived from the original on 6 January 2012.
"Meridia Side Effects, and Drug Interactions". RxList.com. 2007. Archived from the original on 2008-08-09. Retrieved 2007-04-29.
"Meridia (sibutramine hydrochloride monohydrate) Capsules CIV. Full Prescribing Information" (PDF). Abbott Laboratories, North Chicago, IL 60064, U.S.A. Archived (PDF) from the original on 17 February 2017. Retrieved 6 February 2016.
Center for Drug Evaluation and Research (2019-06-28). "FDA Drug Safety Communication: FDA Recommends Against the Continued Use of Meridia (sibutramine)". FDA. Archived from the original on 2022-12-12. Retrieved 2022-12-12.
Wolfe SM, Sasich LD, Barbehenn E (March 19, 2002). "Petition to FDA to ban the diet drug sibutramine (MERIDIA) (HRG Publication #1613)". Public Citizen. Archived from the original on 2006-12-19. Retrieved 2007-04-29.
Hearing of 17 November 2004. "Insider: FDA Won't Protect Public". CBS News. 19 November 2004. Archived from the original on 19 May 2006.
Haslam D (April 2010). "Sibutramine: gone, but not forgotten" (PDF). Pract Diab Int. 27 (3): 96–97. doi:10.1002/pdi.1453. Archived from the original (PDF) on 26 July 2015.
"European Medicines Agency recommends suspension of marketing authorisations for sibutramine" (PDF). European Medicines Agency. January 21, 2010. Archived from the original (PDF) on 2010-04-01.
Andrew Pollack (October 8, 2010). "Abbott Labs Withdraws Meridia From Market". The New York Times. Archived from the original on March 28, 2017. Retrieved February 25, 2017.
"Consumer directed questions and answers about FDA's initiative against contaminated weight loss products". U.S. Food and Drug Administration Center for Drug Evaluation and Research. 22 December 2008. Archived from the original on 17 March 2009. Retrieved 16 December 2019.
34 weight loss products recalled Archived 2009-04-26 at the Wayback Machine, WebMD, 22 April 2009.
"Fake Alli diet pills can pose health risks". CNN.com. January 23, 2010. Archived from the original on 2010-01-25. Retrieved 2010-01-24.
"Herbal diet product poses heart risk". CBC News. March 26, 2010. Archived from the original on March 28, 2010. Retrieved March 26, 2010.
"FDA Alert: Slimming Beauty Bitter Orange Slimming Capsules: Undeclared Drug Ingredient". drugs.com. Archived from the original on 2018-08-25. Retrieved 2018-01-23.
"Press release: Warning over unlicensed herbal Payouji tea and Pai You Guo Slim Capsules". United Kingdom Medicines & Healthcare Products Regulatory Agency. 20 October 2010. Archived from the original on 9 February 2012.
"PRock Marketing, LLC Issues a Voluntary Nationwide Recall of All weight loss formulas and variation of formulas of Reduce Weight Fruta Planta/Reduce Weight Dietary Supplement". United States Food and Drug Administration. Archived from the original on 23 March 2012.
Pope C. "Seizures of illegal medicines rise". The Irish Times. Archived from the original on 2012-10-24. Retrieved 2011-03-25.
"FDA Alert: Slim Xtreme Herbal Slimming Capsule: Undeclared Drug Ingredient". drugs.com. Archived from the original on 2018-08-25. Retrieved 2018-01-23.
"Majestic slimming capsules: Safety advisory". Therapeutic Goods Administration. Australian Government. 9 November 2012. Archived from the original on 3 July 2014. Retrieved 22 November 2012.
Carroll L (19 October 2011). "'Natural' diet pills tainted with banned prescription drug". MSNBC. Archived from the original on 11 January 2012.
Cohen R (12 October 2018). "No Wonder It Works So Well: There May Be Viagra In That Herbal Supplement". NPR.org. Archived from the original on 2018-10-13. Retrieved 2018-10-14.

webmd.com

34 weight loss products recalled Archived 2009-04-26 at the Wayback Machine, WebMD, 22 April 2009.

wsj.com

online.wsj.com

Rockoff JD, Dooren JC (October 8, 2010). "Abbott Pulls Diet Drug Meridia Off US Shelves". The Wall Street Journal. Archived from the original on 11 October 2010. Retrieved 8 October 2010.